1. Home
  2. ESLT vs LEGN Comparison

ESLT vs LEGN Comparison

Compare ESLT & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Elbit Systems Ltd.

ESLT

Elbit Systems Ltd.

HOLD

Current Price

$639.69

Market Cap

21.8B

Sector

Industrials

ML Signal

HOLD

Logo Legend Biotech Corporation

LEGN

Legend Biotech Corporation

HOLD

Current Price

$20.99

Market Cap

5.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ESLT
LEGN
Founded
1966
2014
Country
Israel
United States
Employees
N/A
N/A
Industry
Military/Government/Technical
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
21.8B
5.9B
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
ESLT
LEGN
Price
$639.69
$20.99
Analyst Decision
Buy
Strong Buy
Analyst Count
3
13
Target Price
$550.33
$69.58
AVG Volume (30 Days)
111.3K
2.5M
Earning Date
11-18-2025
11-12-2025
Dividend Yield
0.43%
N/A
EPS Growth
68.63
N/A
EPS
9.87
N/A
Revenue
$7,720,284,000.00
$909,045,000.00
Revenue This Year
$18.47
$68.52
Revenue Next Year
$10.93
$48.63
P/E Ratio
$63.68
N/A
Revenue Growth
18.35
74.75
52 Week Low
$261.01
$20.26
52 Week High
$630.01
$45.30

Technical Indicators

Market Signals
Indicator
ESLT
LEGN
Relative Strength Index (RSI) 84.89 31.83
Support Level $574.29 $21.19
Resistance Level $584.45 $22.07
Average True Range (ATR) 12.28 0.77
MACD 6.98 0.11
Stochastic Oscillator 97.69 25.71

Price Performance

Historical Comparison
ESLT
LEGN

About ESLT Elbit Systems Ltd.

Elbit Systems Ltd is a technology company involved in producing a portfolio of systems and products for aircraft, land, and naval applications. The company's products are used for defense, homeland security, and commercial flight capabilities. Its systems and solutions may be installed on new platforms, or it may perform a comprehensive modernization program to transform a platform. Elbit Systems gives instructions to its customers on the proper maintenance of its products and will provide support team specialists when the customer cannot fix a problem. The company markets its systems and products as a prime contractor or as a subcontractor to government, defense, and homeland security contractors world wide.

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

Share on Social Networks: